Putative fat fighter hits the middle man
- PMID: 19716469
- DOI: 10.1016/j.chembiol.2009.08.003
Putative fat fighter hits the middle man
Abstract
In this issue, Kamisuki and colleagues characterize fatostatin. This compound inhibits the activity of SREBPs, the master transcription factors of lipid homeostasis. This useful laboratory tool also improved the lipid profile of obese mice; does this have clinical implications?
Comment on
-
A small molecule that blocks fat synthesis by inhibiting the activation of SREBP.Chem Biol. 2009 Aug 28;16(8):882-92. doi: 10.1016/j.chembiol.2009.07.007. Chem Biol. 2009. PMID: 19716478
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
